Logo image of UFPT

UFP TECHNOLOGIES INC (UFPT) Stock Fundamental Analysis

NASDAQ:UFPT - Nasdaq - US9026731029 - Common Stock - Currency: USD

208.02  -3.04 (-1.44%)

Fundamental Rating

6

Taking everything into account, UFPT scores 6 out of 10 in our fundamental rating. UFPT was compared to 191 industry peers in the Health Care Equipment & Supplies industry. While UFPT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. UFPT is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings would make UFPT suitable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

UFPT had positive earnings in the past year.
In the past year UFPT had a positive cash flow from operations.
Each year in the past 5 years UFPT has been profitable.
In the past 5 years UFPT always reported a positive cash flow from operatings.
UFPT Yearly Net Income VS EBIT VS OCF VS FCFUFPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

With an excellent Return On Assets value of 9.38%, UFPT belongs to the best of the industry, outperforming 92.15% of the companies in the same industry.
UFPT has a better Return On Equity (17.21%) than 93.19% of its industry peers.
The Return On Invested Capital of UFPT (12.40%) is better than 94.76% of its industry peers.
The Average Return On Invested Capital over the past 3 years for UFPT is above the industry average of 7.68%.
The 3 year average ROIC (11.64%) for UFPT is below the current ROIC(12.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.38%
ROE 17.21%
ROIC 12.4%
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
UFPT Yearly ROA, ROE, ROICUFPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of UFPT (11.69%) is better than 89.01% of its industry peers.
In the last couple of years the Profit Margin of UFPT has grown nicely.
Looking at the Operating Margin, with a value of 16.56%, UFPT belongs to the top of the industry, outperforming 87.96% of the companies in the same industry.
In the last couple of years the Operating Margin of UFPT has grown nicely.
The Gross Margin of UFPT (29.08%) is worse than 75.92% of its industry peers.
In the last couple of years the Gross Margin of UFPT has remained more or less at the same level.
Industry RankSector Rank
OM 16.56%
PM (TTM) 11.69%
GM 29.08%
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
UFPT Yearly Profit, Operating, Gross MarginsUFPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UFPT is still creating some value.
Compared to 1 year ago, UFPT has more shares outstanding
UFPT has more shares outstanding than it did 5 years ago.
UFPT has a worse debt/assets ratio than last year.
UFPT Yearly Shares OutstandingUFPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
UFPT Yearly Total Debt VS Total AssetsUFPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

An Altman-Z score of 5.55 indicates that UFPT is not in any danger for bankruptcy at the moment.
With an excellent Altman-Z score value of 5.55, UFPT belongs to the best of the industry, outperforming 83.25% of the companies in the same industry.
UFPT has a debt to FCF ratio of 3.33. This is a good value and a sign of high solvency as UFPT would need 3.33 years to pay back of all of its debts.
UFPT's Debt to FCF ratio of 3.33 is amongst the best of the industry. UFPT outperforms 86.39% of its industry peers.
UFPT has a Debt/Equity ratio of 0.52. This is a neutral value indicating UFPT is somewhat dependend on debt financing.
UFPT has a Debt to Equity ratio of 0.52. This is in the lower half of the industry: UFPT underperforms 60.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 3.33
Altman-Z 5.55
ROIC/WACC1.36
WACC9.12%
UFPT Yearly LT Debt VS Equity VS FCFUFPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.56 indicates that UFPT has no problem at all paying its short term obligations.
UFPT has a Current ratio (2.56) which is comparable to the rest of the industry.
UFPT has a Quick Ratio of 1.41. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
UFPT has a Quick ratio of 1.41. This is in the lower half of the industry: UFPT underperforms 63.87% of its industry peers.
Industry RankSector Rank
Current Ratio 2.56
Quick Ratio 1.41
UFPT Yearly Current Assets VS Current LiabilitesUFPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.91% over the past year.
Measured over the past years, UFPT shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.55% on average per year.
UFPT shows a strong growth in Revenue. In the last year, the Revenue has grown by 26.07%.
UFPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.52% yearly.
EPS 1Y (TTM)29.91%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%39.07%
Revenue 1Y (TTM)26.07%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.94%

3.2 Future

Based on estimates for the next years, UFPT will show a quite strong growth in Earnings Per Share. The EPS will grow by 15.06% on average per year.
UFPT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.76% yearly.
EPS Next Y17.94%
EPS Next 2Y15.4%
EPS Next 3Y15.06%
EPS Next 5YN/A
Revenue Next Year17.15%
Revenue Next 2Y12.36%
Revenue Next 3Y10.76%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
UFPT Yearly Revenue VS EstimatesUFPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
UFPT Yearly EPS VS EstimatesUFPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

UFPT is valuated quite expensively with a Price/Earnings ratio of 27.37.
74.87% of the companies in the same industry are more expensive than UFPT, based on the Price/Earnings ratio.
UFPT's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 28.29.
A Price/Forward Earnings ratio of 23.21 indicates a rather expensive valuation of UFPT.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 76.96% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.32, UFPT is valued at the same level.
Industry RankSector Rank
PE 27.37
Fwd PE 23.21
UFPT Price Earnings VS Forward Price EarningsUFPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 76.44% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UFPT indicates a rather cheap valuation: UFPT is cheaper than 81.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.06
EV/EBITDA 18.29
UFPT Per share dataUFPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
UFPT has an outstanding profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as UFPT's earnings are expected to grow with 15.06% in the coming years.
PEG (NY)1.53
PEG (5Y)1.16
EPS Next 2Y15.4%
EPS Next 3Y15.06%

0

5. Dividend

5.1 Amount

No dividends for UFPT!.
Industry RankSector Rank
Dividend Yield N/A

UFP TECHNOLOGIES INC

NASDAQ:UFPT (4/21/2025, 2:23:09 PM)

208.02

-3.04 (-1.44%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)05-06 2025-05-06
Inst Owners102.26%
Inst Owner Change0.5%
Ins Owners5.91%
Ins Owner Change2.98%
Market Cap1.60B
Analysts80
Price Target388.62 (86.82%)
Short Float %14.35%
Short Ratio9.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.05%
Min EPS beat(2)3.81%
Max EPS beat(2)14.29%
EPS beat(4)4
Avg EPS beat(4)19.23%
Min EPS beat(4)3.81%
Max EPS beat(4)46.43%
EPS beat(8)7
Avg EPS beat(8)16.51%
EPS beat(12)11
Avg EPS beat(12)34.28%
EPS beat(16)14
Avg EPS beat(16)29.13%
Revenue beat(2)1
Avg Revenue beat(2)3.57%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)7.43%
Revenue beat(4)3
Avg Revenue beat(4)3.48%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)7.43%
Revenue beat(8)6
Avg Revenue beat(8)3.1%
Revenue beat(12)10
Avg Revenue beat(12)5.92%
Revenue beat(16)14
Avg Revenue beat(16)5.81%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0.84%
EPS NQ rev (3m)N/A
EPS NY rev (1m)2.94%
EPS NY rev (3m)2.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.45%
Revenue NY rev (3m)-0.91%
Valuation
Industry RankSector Rank
PE 27.37
Fwd PE 23.21
P/S 3.17
P/FCF 28.06
P/OCF 23.99
P/B 4.66
P/tB 180.5
EV/EBITDA 18.29
EPS(TTM)7.6
EY3.65%
EPS(NY)8.96
Fwd EY4.31%
FCF(TTM)7.41
FCFY3.56%
OCF(TTM)8.67
OCFY4.17%
SpS65.68
BVpS44.63
TBVpS1.15
PEG (NY)1.53
PEG (5Y)1.16
Profitability
Industry RankSector Rank
ROA 9.38%
ROE 17.21%
ROCE 15.11%
ROIC 12.4%
ROICexc 12.71%
ROICexgc 33.38%
OM 16.56%
PM (TTM) 11.69%
GM 29.08%
FCFM 11.29%
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
ROICexc(3y)11.86%
ROICexc(5y)10.07%
ROICexgc(3y)27.75%
ROICexgc(5y)22.85%
ROCE(3y)14.19%
ROCE(5y)11.78%
ROICexcg growth 3Y28.55%
ROICexcg growth 5Y9.48%
ROICexc growth 3Y27.39%
ROICexc growth 5Y1.08%
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF 3.33
Debt/EBITDA 1.8
Cap/Depr 65.62%
Cap/Sales 1.91%
Interest Coverage 10.58
Cash Conversion 67.79%
Profit Quality 96.53%
Current Ratio 2.56
Quick Ratio 1.41
Altman-Z 5.55
F-Score5
WACC9.12%
ROIC/WACC1.36
Cap/Depr(3y)91.16%
Cap/Depr(5y)78.11%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.7%
Profit Quality(3y)58.22%
Profit Quality(5y)76.97%
High Growth Momentum
Growth
EPS 1Y (TTM)29.91%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%39.07%
EPS Next Y17.94%
EPS Next 2Y15.4%
EPS Next 3Y15.06%
EPS Next 5YN/A
Revenue 1Y (TTM)26.07%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.94%
Revenue Next Year17.15%
Revenue Next 2Y12.36%
Revenue Next 3Y10.76%
Revenue Next 5YN/A
EBIT growth 1Y44.82%
EBIT growth 3Y56.96%
EBIT growth 5Y27.59%
EBIT Next Year46.15%
EBIT Next 3Y21.52%
EBIT Next 5YN/A
FCF growth 1Y84.6%
FCF growth 3Y85.71%
FCF growth 5Y17.47%
OCF growth 1Y61.11%
OCF growth 3Y67.03%
OCF growth 5Y16.35%